Delayed Gene Expression and Ischemic Brain Injury
暂无分享,去创建一个
[1] C. Iadecola,et al. Delayed Treatment with Aminoguanidine Decreases Focal Cerebral Ischemic Damage and Enhances Neurologic Recovery in Rats , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] Fangyi Zhang,et al. Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.
[3] D. Salvemini. Regulation of cyclooxygenase enzymes by nitric oxide , 1997, Cellular and Molecular Life Sciences CMLS.
[4] G. Schlaug,et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.
[5] M. Ross,et al. Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage , 1997, The Journal of Neuroscience.
[6] J. K. Muir,et al. Potentiation of oxygen-glucose deprivation-induced neuronal death after induction of iNOS. , 1996, Stroke.
[7] Fausto Viader,et al. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra , 1996, Annals of neurology.
[8] M. Ross,et al. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. , 1996, Stroke.
[9] M. Moskowitz,et al. Emerging treatments for stroke in humans. , 1996, Trends in pharmacological sciences.
[10] V Beaudouin,et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. , 1996, Stroke.
[11] P. Booker,et al. A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging. , 1995, Stroke.
[12] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[13] M. Ross,et al. Inducible Nitric Oxide Synthase Gene Expression in Brain following Cerebral Ischemia , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] B. Siewert,et al. Acute human stroke studied by whole brain echo planar diffusion‐weighted magnetic resonance imaging , 1995, Annals of neurology.
[15] J. Mong,et al. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures , 1994, Neuropharmacology.
[16] Shuxian Hu,et al. Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. , 1994, The Journal of infectious diseases.
[17] D. Choi,et al. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS , 1994, Neuron.
[18] W. Sessa. The nitric oxide synthase family of proteins. , 1994, Journal of vascular research.
[19] M. Currie,et al. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. , 1994, The Journal of clinical investigation.
[20] Y. Vodovotz,et al. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. , 1994, Journal of immunology.
[21] William L. Smith,et al. Pharmacology of Prostaglandin Endoperoxide Synthase Isozymes‐1 and‐2 a , 1994, Annals of the New York Academy of Sciences.
[22] M. Currie,et al. Nitric oxide activates cyclooxygenase enzymes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[23] Carol A. Barnes,et al. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids , 1993, Neuron.
[24] M Chopp,et al. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. , 1993, The American journal of pathology.
[25] K Wienhard,et al. Progressive Derangement of Periinfarct Viable Tissue in Ischemic Stroke , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] C. Nathan,et al. Nitric oxide and macrophage function. , 1997, Annual review of immunology.
[27] K. Welch. Primer on cerebrovascular diseases , 1997 .
[28] D. Giulian. Reactive Microglia and Ischemic Injury , 1997 .
[29] J Garthwaite,et al. Nitric oxide signaling in the central nervous system. , 1995, Annual review of physiology.
[30] C. Iadecola,et al. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. , 1995, The American journal of physiology.
[31] S. Gross,et al. Nitric oxide: pathophysiological mechanisms. , 1995, Annual review of physiology.
[32] O. Griffith,et al. Nitric oxide synthases: properties and catalytic mechanism. , 1995, Annual review of physiology.
[33] K. Seibert,et al. Mediation of inflammation by cyclooxygenase-2. , 1995, Agents and actions. Supplements.
[34] J. Garcìa,et al. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). , 1994, The American journal of pathology.
[35] S. Higuchi,et al. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. , 1993, General pharmacology.
[36] P. Weinstein,et al. Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.